Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000073

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 1:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 31, 2017P1,000$0.0668A21,028,249D
Common StockMay 31, 2017P1,000$0.0668A21,029,249D
Common StockMay 31, 2017P1,000$0.0667A21,030,249D
Common StockMay 31, 2017P1,000$0.066A21,031,249D
Common StockMay 31, 2017P1,000$0.066A21,032,249D
Common StockMay 31, 2017P1,000$0.0696A21,033,249D
Common StockMay 31, 2017P1,000$0.0689A21,034,249D
Common StockMay 31, 2017P1,000$0.0629A21,035,249D
Common StockMay 31, 2017P1,000$0.061A21,036,249D
Common StockMay 31, 2017P1,000$0.0628A21,037,249D
Common StockMay 31, 2017P1,000$0.0629A21,038,249D
Common StockMay 31, 2017P1,000$0.0629A31,039,249D
Common StockMay 31, 2017P1,000$0.057A21,040,249D
Common StockMay 31, 2017P1,000$0.058A21,041,249D
Common StockMay 31, 2017P1,000$0.0595A21,042,249D
Common StockJun 1, 2017P1,000$0.051A21,043,249D
Common StockJun 1, 2017P1,000$0.051A21,044,249D
Common StockJun 1, 2017P1,000$0.0549A21,045,249D
Common StockJun 1, 2017P1,000$0.0549A21,046,249D
Common StockJun 1, 2017P1,000$0.057A21,047,249D
Common StockJun 1, 2017P1,000$0.057A21,048,249D
Common StockJun 1, 2017P1,000$0.057A21,049,249D
Common StockJun 1, 2017P1,000$0.0569A21,050,249D
Common StockJun 1, 2017P1,000$0.057A21,051,249D
Common StockJun 1, 2017P1,000$0.057A21,052,249D
Common StockJun 1, 2017P1,000$0.057A21,053,249D
Common StockJun 1, 2017P1,000$0.057A21,054,249D
Common StockJun 1, 2017P1,000$0.0575A21,055,249D
Common StockJun 1, 2017P1,000$0.0575A21,056,249D
Common StockJun 1, 2017P50$0.0575A21,056,299D

Table II — derivative securities

No Table II lines on this filing.